Результаты поиска - Ulrike K Buchwald
- Отображение 1 - 8 результаты of 8
-
1
Response to Shami et al. 'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong' (Hum Vacc... по Ulrike K. Buchwald, Temitope Folaranmi, Thomas Weiss
Опубликовано 2021Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
2
An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among heal... по Shahrul Mt-Isa, Justin R. Chumbley, Emma L. Crawford, Natalie Banniettis, Ulrike K. Buchwald, Jessica Weaver, Thomas Weiss
Опубликовано 2023Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
3
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C по Yaru Shi, Katrina M. Nolan, Robert L. Burton, Tulin Shekar, Rocio D. Murphy, Natalie Banniettis, Luwy Musey, Ulrike K. Buchwald
Опубликовано 2023Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
4
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children по Timothy J Chapman, Liset Olarte, Ghassan Dbaibo, Avril Melissa Houston, Gretchen Tamms, Robert Lupinacci, Kristen Feemster, Ulrike K Buchwald, Natalie Banniettis
Опубликовано 2024Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
5
Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review по Elmira Flem, Celine Mouawad, Arto A. Palmu, Heather Platt, Kelly D. Johnson, E. David McIntosh, Jacobo Abadi, Ulrike K. Buchwald, Kristen Feemster
Опубликовано 2024Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
6
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a... по Randall Severance, Howard Schwartz, Ron Dagan, Laurie Connor, Jianing Li, Alison Pedley, Jonathan Hartzel, Tina M. Sterling, Katrina M. Nolan, Gretchen M. Tamms, Luwy K. Musey, Ulrike K. Buchwald, for the V114-021 (PNEU-FLU)
Опубликовано 2022Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
7
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccin... по Laura L. Hammitt, Dean Quinn, Ewa Janczewska, Francisco J. Pasquel, Richard Tytus, K. Rajender Reddy, Katia Abarca, Ilsiyar M. Khaertynova, Ron Dagan, Rachel Dawson, Jennifer McCauley, Tulin Shekar, Wei Fu, Alison Pedley, Tina Sterling, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald
Опубликовано 2023Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
8
Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older по Ulrike K. Buchwald, Charles P. Andrews, John Ervin, James T. Peterson, Gretchen M. Tamms, David Krupa, Patrick Ajiboye, Lucy Roalfe, Andrea L. Krick, Tina M. Sterling, Meihua Wang, Jason C. Martin, Jon E. Stek, Melvin A. Kohn, Temitope Folaranmi, Chitrananda Abeygunawardana, Jonathan Hartzel, Luwy K. Musey, the V110-029 Study Group
Опубликовано 2021Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...